Data Foundry

Drug recalls 2026

Zoladex — Class II drug recall D-0875-2026

Ongoing recall by TerSera Therapeutics LLC, reported 2026-10-07, distributed nationwide. Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for

Recall numberD-0875-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmTerSera Therapeutics LLC, Deerfield, IL, United States
Recall initiated2026-08-31
Classified2026-09-28
Reported by FDA2026-10-07
DistributedNationwide (US)
Quantity296 cartons
Reason classestemperature control
NDC70720-0950, 70720-0950-36
Lot numbersYN0099
Expiration dates2028-01-31

Product

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

Reason for recall

Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0875-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-10-13. Not affiliated with or endorsed by FDA. Not medical or legal advice.